22nd Century Group to Participate in the HC Wainwright Conference on September 10, 2024

Rhea-AI Summary

22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, has announced its participation in the HC Wainwright Conference on September 10, 2024 at the Lotte New York Palace Hotel. The company, known for its VLN® brand with 95% less nicotine, invites investors to register and request meetings with management through their HC Wainwright representatives.

22nd Century Group will also make an updated investor presentation available online at their investor relations website. This conference participation highlights the company's commitment to engaging with investors and showcasing their innovative approach to tobacco harm reduction.

News Market Reaction – XXII

+0.80%

+0.80% Session move

In the trading session that priced this news, XXII gained 0.80%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Mocksville, North Carolina--(Newsfile Corp. - September 6, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company leading the fight against nicotine with its 95% less nicotine brand VLN® focused on nicotine harm reduction and contract manufacturing, today announced that it will participate in the HC Wainwright Conference on September 10, 2024 at the Lotte New York Palace Hotel. Investors can register and request meetings with management via their HC Wainwright representative.

The Company will post an updated investor presentation online at https://ir.xxiicentury.com/.

About 22nd Century Group, Inc.

22nd Century Group, Inc. (NASDAQ: XXII) is an agricultural biotechnology company focused on tobacco harm reduction by offering tobacco products with 95% less nicotine, designed to improve health and wellness by helping smokers smoke less. Backed by comprehensive and extensively patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, the Company has pioneered the development of high-yield, proprietary reduced nicotine content (RNC) tobacco plants and clinically validated RNC cigarette products. The Company received the first and only FDA Modified Risk Tobacco Product (MRTP) authorization for a combustible cigarette in December 2021. The Company is a subsequent participating manufacturer under the Master Settlement Agreement ("MSA") and vertically integrated for the production of both its own products and contract manufacturing operations ("CMO"), which consist primarily of branded filtered cigars and conventional cigarettes.

Learn more at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.

Learn more about VLN^® at tryvln.com.

Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/222415

FAQ

When is 22nd Century Group (XXII) participating in the HC Wainwright Conference?

22nd Century Group (XXII) is participating in the HC Wainwright Conference on September 10, 2024.

Where is the HC Wainwright Conference being held for 22nd Century Group (XXII)?

The HC Wainwright Conference is being held at the Lotte New York Palace Hotel.

How can investors meet with 22nd Century Group (XXII) management at the conference?

Investors can register and request meetings with 22nd Century Group (XXII) management through their HC Wainwright representative.

What is 22nd Century Group's (XXII) main product focus?

22nd Century Group (XXII) focuses on nicotine harm reduction with its VLN® brand, which contains 95% less nicotine than traditional cigarettes.

Where can investors find 22nd Century Group's (XXII) updated investor presentation?

Investors can find 22nd Century Group's (XXII) updated investor presentation on their investor relations website at https://ir.xxiicentury.com/.